Arcturus Therapeutics Holdings Inc.ARCTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank71
3Y CAGR-8.8%
5Y CAGR+14.2%
Year-over-Year Change
Research and development spending
3Y CAGR
-8.8%/yr
vs +71.7%/yr prior
5Y CAGR
+14.2%/yr
Recent deceleration
Acceleration
-80.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $112.21M | -42.5% |
| 2024 | $195.16M | +1.6% |
| 2023 | $192.13M | +30.0% |
| 2022 | $147.75M | -15.0% |
| 2021 | $173.76M | +200.4% |
| 2020 | $57.85M | +72.0% |
| 2019 | $33.64M | +98.1% |
| 2018 | $16.98M | +6.7% |
| 2017 | $15.92M | -13.4% |
| 2016 | $18.39M | - |